OxyNov
OxyNov is a Quebec-based medical device company that develops and commercializes FreeO2, an automated closed-loop oxygen titration device that continuously adjusts oxygen flow to maintain target SpO2 levels in hospital patients. It serves ICUs, emergency departments, and surgical units across Canada, Europe, the Middle East, and Latin America via a distributor network.
- Company typePrivate
- Founded2009
- HeadquartersQuebec, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What OxyNov does
OxyNov is a privately-held Canadian medical device company headquartered in Quebec City, founded in 2009 by physicians Dr. Erwan L'Her (CHU de Brest, INSERM) and Dr. François Lellouche (Quebec Heart and Lung Institute / IUCPQ). The company designs, manufactures, and commercializes FreeO2, a Class IV medical device (Health Canada) and CE MDR-marked (EU 2017/745) automated closed-loop oxygen titration and weaning system. FreeO2 continuously measures patient oxygen saturation via pulse oximetry and automatically adjusts oxygen flow (0-20 L/min) every second to maintain clinician-defined target SpO2 levels, addressing a clinical problem — manual oxygen titration — that has remained substantially unchanged since 1910.
The core technology is a closed-loop feedback control system derived from 12+ years of research at Université Laval and IUCPQ, validated on more than 1,000 patients across peer-reviewed studies in European Respiratory Journal, BMJ Open, International Journal of COPD, and Journal of Critical Care. Documented clinical outcomes include a 29% reduction in hospital length of stay for COPD exacerbation patients, 21% reduction in cost of care at 180 days, 50% reduction in oxygen consumption, and SpO2 maintenance within target zone more than 90% of the time. The device supports adult, pediatric, and neonatal populations across ICUs, emergency departments, surgical and post-anesthesia care units, and chronic respiratory failure management.
OxyNov operates a distributor-mediated enterprise sales model targeting hospitals and acute-care facilities. Revenue is generated primarily from hardware sales of the FreeO2 device, supplemented by professional services revenue from the OxyNov Academy continuing medical education platform. Distribution is executed through regional commercial partners: Novus Medical Inc. (exclusive Canada), Vygon Group (France/Europe — also a 20% equity holder since September 2018), Southmedic (Canada), Professional Medical Supplies W.L.L. (Qatar/Middle East), and UniHA referencing (French public hospitals). The company serves markets in Canada, France, broader Europe, the Middle East, and Latin America, with the United States explicitly out of scope pending FDA clearance. A home-care version called FreeDom is in the product pipeline.
OxyNov firmographics
Firmographics- Name
- OxyNov
- Legal name
- OxyNov Inc
- Website
- https://oxynov.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- OxyNov is a Quebec-based medical device company that develops and commercializes FreeO2, an automated closed-loop oxygen titration device that continuously adjusts oxygen flow to maintain target SpO2 levels in hospital patients. It serves ICUs, emergency departments, and surgical units across Canada, Europe, the Middle East, and Latin America via a distributor network.
- Ownership category
- akta.pro rank
OxyNov industry classification
Industry- Product category
- Respiratory Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)
- akta.pro secondary industries
- Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI), Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
Keywords
Where OxyNov is headquartered
LocationHeadquarters
- HQ city
- Quebec
- HQ country
- Canada
- HQ region
- North America
Offices3 records
Markets served
OxyNov business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- FreeO2 Medical Device Sales: OxyNov generates revenue from the sale of its FreeO2 automated oxygen therapy devices to hospitals and healthcare facilities. The device is sold as a Class IV medical device (Health Canada) and CE-marked (MDR EU 2017/745). Distribution occurs through commercial partners in various geographies.
- OxyNov Academy Training Services: The company provides continuing medical education and training for FreeO2 users through the OxyNov Academy platform, developed and delivered by expert physicians. Training is offered as part of device onboarding and ongoing education.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
OxyNov product offering
Product offeringCore offering
OxyNov designs, manufactures, and commercializes the FreeO2 automated closed-loop oxygen therapy device, a Class IV medical device that continuously measures patient SpO2 via pulse oximetry and automatically adjusts oxygen flow (0–20 L/min) in real time to maintain a clinician-defined target saturation, including automated weaning. The company sells the device to hospitals and acute care facilities, complemented by the OxyNov Academy continuing medical education platform for clinical users.
Product overview
OxyNov offers a single unified product, the FreeO2 device, which is an innovative automated closed-loop oxygen therapy system. Developed in Quebec and commercialized internationally, FreeO2 continuously monitors patient oxygen saturation (SpO2) via an integrated oximeter and automatically adjusts oxygen flow to maintain clinician-defined target levels. The company complements this core medical device with OxyNov Academy, a medical education platform that provides training for healthcare professionals on oxygen therapy optimization and FreeO2 usage. A planned home version called FreeDom is under development for future home care applications.
Differentiator
Problem solved
Functional benefit
Products and services
- FreeO2 FreeO2 is a Class IV medical device (Health Canada) and CE MDR-marked automated closed-loop oxygen therapy device for hospitals and acute care facilities. It continuously measures patient SpO2 via pulse oximetry and automatically adjusts oxygen flow between 0 and 20 L/min every second to maintain the clinician-defined target saturation, performs automatic weaning as patients improve, and provides up to 72 hours of cardiorespiratory trend monitoring. Intended for adult, pediatric, and neonatal patients in ICUs, ERs, and surgical/post-anesthesia care units.
- OxyNov Academy OxyNov Academy is a continuing medical education platform dedicated to oxygen therapy and FreeO2 users, providing comprehensive training modules developed, verified, and presented by expert physicians. It supports device onboarding and ongoing education for healthcare professionals.
Quantifiable outcome
- 29% reduction in hospital stay for COPD patients (6.7 days vs 9.5 days)
- +4 more outcomes
Companies that use OxyNov
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
OxyNov technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
OxyNov partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered major and core.
- Novus Medical Inc.majorExclusive Canadian distributor for FreeO2, based in Ontario. Over 30 years of experience in medical equipment sales and support across Canada, specializing in respiratory devices and pulmonary diagnosis.
- Professional Medical Supplies W.L.L.majorCommercial partner for Qatar and Middle East region. Responsible for first FreeO2 installation outside Europe at Hamad General Hospital in Doha, Qatar.
- SouthmedicmajorSouthmedic is a Canadian commercial partner for FreeO2. A privately owned corporation established in 1983 providing innovative healthcare products, and a Platinum member of Canada's 50 Best Managed Companies.
- UniHAcoreUniHA is the first public hospital purchasing group in France, providing centralized procurement for French public hospitals. Its official referencing of FreeO2 enables French hospital procurement.
- Université LavalcoreFreeO2 prototype was developed at Université Laval's Department of Electrical and Computer Engineering. The company originated from research collaboration with the university and remains a key academic partner.
- Quebec Heart and Lung Institute (IUCPQ)coreOxyNov was founded at the Quebec Heart and Lung Institute (QHLI/IUCPQ) with support from all pulmonologists. The Institute served as the primary clinical research site. IUCPQ Foundation co-invested in FreeO2 development.
- INSERM / University of Brest (CHU de Brest)coreCo-founder Dr. Erwan L'Her is head of the medical ICU and INSERM researcher at CHU de Brest. INSERM and the University of Brest contributed to clinical research and validation of the FreeO2 technology.
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
OxyNov competitors and assessment
Company assessmentBroad incumbents
- Getinge: Swedish provider of hospital and ICU equipment including ventilators and anesthesia systems. Comparable as a broad incumbent in the same acute care hospital procurement ecosystem where OxyNov sells.
- Teleflex: Diversified medical device company with respiratory care offerings including oxygen delivery and airway management products. Comparable as a hospital-focused respiratory device competitor with overlapping ICU and surgical customer base.
- ResMed: Global leader in sleep apnea, COPD, and home oxygen therapy devices. Comparable as a respiratory therapy player with overlapping COPD and oxygen therapy markets, particularly relevant for FreeDom home oxygen expansion.
- Philips Respironics: Major player in hospital and home oxygen therapy, ventilation, and sleep apnea devices. Comparable as a broad incumbent offering oxygen concentrators and respiratory care solutions across hospital and home settings.
- Fisher & Paykel Healthcare: New Zealand-based global leader in respiratory care, humidification, and neonatal products. Comparable in addressing hospital respiratory therapy needs with a broader portfolio spanning oxygen delivery and patient monitoring.
- Drägerwerk: Major German manufacturer of ICU ventilators, anesthesia, and patient monitoring equipment. Directly comparable as a broad incumbent in respiratory and ICU care with overlapping hospital customer base and oxygen/ventilation therapy portfolio.
- Hamilton Medical: Swiss manufacturer of mechanical ventilators and respiratory care devices for ICUs and hospitals. Comparable as an established respiratory device player serving the same ICU and acute care customer base as OxyNov.
Emerging players
- Invacare: Manufacturer of home oxygen therapy devices and respiratory equipment. Comparable as an oxygen therapy device maker; relevant benchmark for FreeDom home oxygen product strategy.
- Chart Industries (CAIRE): Through its CAIRE brand, Chart Industries manufactures medical oxygen concentrators and respiratory products. Comparable as an oxygen therapy device provider serving similar hospital and home patient populations.
Direct peers
- Masimo: US-based leader in pulse oximetry and patient monitoring technology. Comparable as FreeO2 relies on continuous SpO2 measurement; Masimo's SET pulse oximetry is the gold standard and represents both a complementary technology and potential integration or competitive overlap.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
OxyNov social profiles
Digital presenceOxyNov compliance and trust
Trust signalCompliance3 records
OxyNov financial estimates
Financial estimateRevenue estimate
Valuation estimate
OxyNov leadership team
Management profileNumber of profiles
Profiles7 records
OxyNov funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OxyNov M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OxyNov
What does OxyNov do?
OxyNov designs, manufactures, and commercializes the FreeO2 automated closed-loop oxygen therapy device, a Class IV medical device that continuously measures patient SpO2 via pulse oximetry and automatically adjusts oxygen flow (0–20 L/min) in real time to maintain a clinician-defined target saturation, including automated weaning. The company sells the device to hospitals and acute care facilities, complemented by the OxyNov Academy continuing medical education platform for clinical users.
Is OxyNov a public or private company?
OxyNov is a private company. It is classified as venture growth investor backed and is currently operating.
When was OxyNov founded?
OxyNov was founded in 2009. It employs 11 to 50 people.
Where is OxyNov based?
OxyNov is headquartered in Quebec, Canada, in the North America region.
How does OxyNov make money?
Two revenue lines are on record. FreeO2 Medical Device Sales are the primary driver. The others are oxyNov Academy Training Services.
Who are OxyNov's main competitors?
Broad incumbents on record are Getinge, Teleflex, ResMed, Philips Respironics, Fisher & Paykel Healthcare, Drägerwerk and Hamilton Medical. Emerging players are Invacare and Chart Industries (CAIRE). Masimo is listed as a direct peer.
Does OxyNov have an API?
No public API is recorded for OxyNov.
What industry is OxyNov in?
OxyNov's product category is Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate). Its NAICS code is 334510 and its SIC code is 3841.